Prelude Capital Management’s Curis CRIS Stock Holding History

Prelude Capital Management’s Portfolio CRIS Stock Details CRIS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-27	Closed	-$122K	–	1687
2021 Q1	$122K	Buy	+27	New	+$113K	﹤0.01%	1401
2018 Q4	–	Sell	-1	Closed	-$1K	–	1831
2018 Q3	$1K	Hold	1	–	–	﹤0.01%	1681
2018 Q2	$1K	Hold	1	–	–	﹤0.01%	1607
2018 Q1	$2K	Hold	1	–	–	﹤0.01%	1450
2017 Q4	$2K	Buy	+1	New	+$2.35K	﹤0.01%	1299
2017 Q3	–	Hold	0	–	-$1K	–	1665
2017 Q2	–	Hold	0	–	–	–	1549
2017 Q1	–	Hold	0	–	–	–	1537
2016 Q3	–	Sell	-1	Closed	-$2K	–	1622
2016 Q2	$2K	Hold	1	–	–	﹤0.01%	1504
2016 Q1	$2K	Sell	1 -13	-93%	-$43.8K	﹤0.01%	1217
2015 Q4	$79K	Buy	14 +4	+40%	+$19.5K	0.01%	899
2015 Q3	$39K	Buy	+10	New	+$56.6K	0.01%	1116
2014 Q3	–	Sell	-28	Closed	-$106K	–	1896
2014 Q2	$106K	Buy	28 +27	+2,700%	+$110K	0.01%	1071
2014 Q1	$7K	Buy	+1	New	+$6.01K	﹤0.01%	1783
2013 Q4	–	Sell	-4	Closed	-$35K	–	1653
2013 Q3	$35K	Buy	+4	New	+$32.3K	0.01%	1038

Other funds holding CRIS

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

OCA

Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

SCM

Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

Prelude Capital Management's CRIS Position: Q2 2021 in Review

Prelude Capital Management sold out of Curis (CRIS) in Q2 2021, closing a stake of 27 shares — an estimated $122K sold.

Prelude Capital Management first reported a position in CRIS in Q3 2013 and held it in 12 quarters. The position peaked at $122K in Q1 2021. 127 funds tracked by Wall St. Rank hold CRIS as of Q2 2021.

Prelude Capital Management reported no remaining Curis position as of Q2 2021 after selling out during the quarter.
Prelude Capital Management sold 27 Curis shares in Q2 2021, an estimated $122K.
Prelude Capital Management first reported a position in Curis in Q3 2013 and held it in 12 quarters.
Prelude Capital Management's Curis position peaked at $122K in Q1 2021.
127 funds tracked by Wall St. Rank held Curis as of Q2 2021.

Based on Prelude Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.